DoD Awards Biosearch Second Phase II SBIR Grant, This Time for Rickettsial Pathogens | GenomeWeb

Biosearch Technologies said yesterday that it has been awarded a Phase II Small Business Innovation Research grant from the Department of Defense to further design and develop quantitative PCR-based assays for pathogens of military importance.

The grant, worth more than $750,000, will support the development of qRT-PCR primers and probes to detect six rickettsial pathogens, four of which are listed in the top 25 of the Global Risk Severity Index compiled by the Armed Forces Medical Intelligence Center, Biosearch said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.